OBJECTIVE
To study the features of clinical manifestations, diagnosis of ovarian vein thrombosis in the postpartum period, as well as methods of treating women in labor with this complication.
MATERIAL AND METHODS
A retrospective analysis of the medical records of 156 patients was con-ducted. The 1st (main) group included 63 women in labor with a diagnosis of «ovarian vein thrombosis». The 2nd (control) group included 93 women in labor without thromboembolic com-plications. The control group initially did not differ from the main group in age, number of preg-nancies and method of delivery.
RESULTS
There were no complaints in 62 (98.4%) of 63 patients with gonadal vein thrombosis. The diagnosis was established on the 3rd-4th day during screening ultrasound, which was per-formed on all women after labor to assess uterine involution. In the 1st group, varicose veins of the lower extremities were observed more often than in the 2nd group — in 13 (20.6%) of 63 and in 8 (8.6%) of 93 patients, respectively (p=0.03). The groups were comparable in terms of the frequency of gynecological diseases, reproductive history, main characteristics of labor, and the risk of developing venous thromboembolic complications. Thrombosis of the right gonadal vein was diagnosed in 55 (87.3%), left — in 7 (11.1%) of 63 parturient women of the 1st group, bilat-eral — in 1 (1.6%) patient of the main group. Flotation of the thrombus apex was observed in 32 (50.8%) patients of the 1st group, among them 15 (46.9%) had a floating thrombus of the inferior vena cava. Effective conservative treatment was carried out in 59 (93.7%) parturient women of the main group. Surgical treatment (thrombectomy from the inferior vena cava, ligation of the right ovarian vein) was performed in 4 (6.3%) patients of the main (1st) group.
CONCLUSION
Most patients with gonadal vein thrombosis had no complaints and clinical signs of the disease, as well laboratory tests. Ultrasound angioscanning was the optimal diagnostic meth-od. Therapy with therapeutic doses of low-molecular heparins resulted in complete resorption of the thrombus in the affected vessel.
